Core Insights - The State Administration for Market Regulation announced plans to conduct fair competition reviews by 2025, urging policy-making bodies to rectify measures that hinder a unified market and fair competition [1] - The agency will address a series of monopoly cases in the pharmaceutical sector, aiming to significantly reduce the prices of involved drugs [1] - A total of 14,600 cases of unfair competition will be investigated, with a focus on comprehensive rectification of "involution-style" competition [1] Group 1 - The organization will implement fair competition review checks to promote market integrity [1] - There will be a crackdown on monopolistic practices in the pharmaceutical industry, leading to substantial price reductions [1] - The agency plans to investigate 14,600 cases of unfair competition, enhancing oversight on key enterprises [1] Group 2 - Measures will be taken to mitigate "price wars" and "subsidy wars" through cost investigations and price inspections [1] - The initiative aims to guide and regulate competitive practices among major companies [1]
市场监管总局：2025年查办各类反不正当竞争案件1.46万件 有效推动“价格战”“补贴战”及时降温
Jing Ji Guan Cha Wang·2026-02-05 02:35